What's Jewish About Breast Cancer?

The Latest Research on Genetic Risk Factors, Prevention, Detection and Treatment from Beer-Sheva to the Bay Area American Associates,
Ben-Gurion University of the Negev Northwest Region and The Israeli Cultural Connection

invite you to

What's Jewish About Breast Cancer?

The Latest Research on Genetic Risk Factors, Prevention, Detection and Treatment from Beer-Sheva to the Bay Area

with

Michael Koretz, M.D.
Director, Breast Health Center of the Negev
Soroka University Medical Center
Lecturer, Faculty of Health Sciences
Ben-Gurion University of the Negev

and

Irene Wapnir, M.D.
Director of Breast Surgical Oncology Fellowship Training Program
Chief of Breast Surgery, Professor of Surgery
Stanford University School of Medicine

Tuesday, December 17, 2013

7:30 p.m. to 9:00 p.m.

Oshman Family Jewish Community Center
3921 Fabian Way
Palo Alto, California

One in forty women of Ashkenazi Jewish descent carries a gene mutation that is likely to cause breast cancer. Join us for an important conversation with internationally renowned breast health specialists, Michael Koretz, M.D. and Irene Wapnir, M.D., about this risk and what we can do to protect our health.

$8 OFJCC members, $10 non-members, $12 at the door

For more information, contact 650-223-8692 or icc@paloaltojcc.org

Dr. Michael Koretz made aliyah in 1992 with his family to Israel, where he established the multidisciplinary Breast Health Center of the Negev at Soroka University Medical Center in Beer-Sheva. The first of its kind in the Middle East, the Center serves a diverse population in southern Israel, providing comprehensive breast health care on par with world-class institutions across America and Europe. Dr. Koretz’s primary research interests include oncology and the psychosocial effects of breast cancer. He also teaches medical students at Ben-Gurion University of the Negev, and is invited to speak at conferences all over the world. Dr. Koretz is a graduate of Boston University School of Medicine, and has served on the Emory University faculty in surgical oncology.

Dr. Irene Wapnir has had her clinical practice at Stanford Cancer Institute’s Women’s Cancer Center since 2000. She has been involved in several clinical trials focused on the management of locally recurrent breast cancer. She also maintains a small laboratory that investigates new targeted therapies in breast cancer and brain metastasis. In December 2012, Dr. Wapnir was a Dozor Visiting Professor at Ben-Gurion University of the Negev and Soroka University Hospital’s Breast Health Center. Dr. Wapnir earned her medical degree at Universidad Autonoma Metropolitana in Mexico City. She completed her surgical residency at New York Medical College, and continued training in breast disease at the University of Medicine and Dentistry of New Jersey.